HCID 58485290, compound → HCID 58485312, compound

HRID 1046091Notes

Reaction equation

HRID 1046091 reaction equation
[OH:1][C:2]([CH3:35])([CH3:34])[CH2:3][C@@:4]1([C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)[O:9][C:8](=[O:10])[N:7]([C@H:11]([C:13]2[CH:18]=[CH:17][C:16](B3OC(C)(C)C(C)(C)O3)=[CH:15][CH:14]=2)[CH3:12])[CH2:6][CH2:5]1.Br[C:37]1[CH:38]=[N:39][C:40]([N:43]2[CH:47]=[C:46]([CH3:48])[N:45]=[C:44]2[CH3:49])=[N:41][CH:42]=1>>[CH3:49][C:44]1[N:43]([C:40]2[N:39]=[CH:38][C:37]([C:16]3[CH:15]=[CH:14][C:13]([C@@H:11]([N:7]4[CH2:6][CH2:5][C@:4]([CH2:3][C:2]([OH:1])([CH3:34])[CH3:35])([C:28]5[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=5)[O:9][C:8]4=[O:10])[CH3:12])=[CH:18][CH:17]=3)=[CH:42][N:41]=2)[CH:47]=[C:46]([CH3:48])[N:45]=1

Participants

3

Procedure

The title compound was prepared from (S)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-2-one and 5-bromo-2-(2,4-dimethyl-1H-imidazol-1-yl)-pyrimidine following a procedure analogous to that described in Example 1 Step 2. LC-MS Method 2 tR=0.962 min, m/z=526.3; 1H NMR (CD3OD) 0.86 (s, 3H), 1.16 (s, 3H), 1.49 (m, 3H), 2.06 (m, 2H), 2.12 (m, 1H), 2.20 (s, 3H), 2.35-2.48 (m, 2H), 2.82 (s, 3H), 3.03 (m, 1H), 5.53 (m, 1H), 7.07 (m, 2H), 7.19-7.32 (m, 6H), 7.45 (m, 2H), 7.80 (m, 1H), 8.96 (s, 2H).

Sources & evidence

ORD record
ord-d012e5e246d142b2bc12f1125a8df794
Source dataset
uspto-grants-2013_10
Patent number
US08569292B2

Reaction notes

Loading…